|
市場調査レポート
商品コード
1211025
吸入・経鼻製品受託サービスプロバイダーの世界市場規模調査・予測:製品別、サービス別、地域別分析、2022-2029年Global Inhaled and Intranasal Products Contract Service Providers Market Size study & Forecast, by Product by Services and Regional Analysis, 2022-2029 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
吸入・経鼻製品受託サービスプロバイダーの世界市場規模調査・予測:製品別、サービス別、地域別分析、2022-2029年 |
出版日: 2023年01月25日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の吸入・経鼻製品受託サービスプロバイダー市場は、2021年に約22億1000万米ドルと評価され、予測期間2022-2029年には8.5%を超える健全な成長率で成長すると予測されています。
吸入・経鼻製品は、喘息の予防やアレルギー、花粉症、一部の鼻の症状の管理に使用される特別に設計された医療機器です。サービス提供者契約は、特定のサービスを提供する当事者とそのサービスを受ける当事者との間で、対価を支払って専門的なサービスを提供する際の関係を規定する契約です。効果的で高度な呼吸器系デバイスの認知度向上、高齢者人口の増加、規制遵守の容易さが、全世界の市場需要に向けた主な要因となっています。
慢性呼吸器疾患の増加は、市場成長の促進要因として作用しています。世界保健機関(WHO)の報告によると、呼吸器疾患による死亡は年間約300万人(世界の全死亡者の6%)、COPDによる死亡の約90%は低・中所得国の70歳以上で発生しており、死亡原因の第3位を占めています。また、約2億6,200万人の患者様が喘息に苦しんでいると推定されており、喘息はお子様が罹患することが多い疾患です。このように、これらの要因は、直接吸入および経鼻製品の受託サービス事業者の成長に関連しています。また、高度な技術の開発への投資の上昇だけでなく、最新の技術ベースのネブライザーの立ち上げは、予測年間にわたり様々な有利な機会を提示しています。しかし、製品承認のための厳しい政府規制が、2022年から2029年の予測期間を通じて市場成長を制限しています。
世界の吸入・経鼻製品契約サービスプロバイダ市場の調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の世界地域です。アジア太平洋地域は、呼吸器系疾患の発生率の増加、政府のイニシアティブの高まり、いくつかの政策の実施により、収益面で市場を独占しています。一方、北米は、有利な保険償還シナリオや、市場空間における多数の受託製造業者の存在などの要因により、予測期間中に最高のCAGRで成長すると予想されます。
本調査の目的は、近年におけるさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
Global Inhaled and Intranasal Products Contract Service Providers Market is valued at approximately USD 2.21 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Inhaled and intranasal products is a specially designed medical device that is used for the prevention of asthma and the management of allergy, hayfever, and some nasal conditions. The contract service providers are contract regulates relations in the rendering of professional services between a party which offers the specified service and another the recipient thereof in exchange for a payment. The growing awareness of the effective and advanced respiratory devices, increase in geriatric population, and ease of regulatory compliance are the primary factors that are attributing towards the market demand across the globe.
The increasing incidences of chronic respiratory diseases is acting as a catalyzing factor for the growth of the market. The World Health Organization (WHO) reported that the respiratory disease infections as the third leading cause of mortality, which is accounting for around 3 million deaths year (or 6% of all fatalities worldwide), with nearly 90% of COPD fatalities occurring in individuals over 70 from low- and middle-income nations. Also, there are around 262 million patients were estimated to suffer from asthma, which commonly affects children. Thus, theses aforementioned factors are directly associated growth of the inhaled and intranasal products contract service providers. Moreover, rising investment in the development of advanced technology, as well as the rising launch of the latest technology-based nebulizers are presenting various lucrative opportunities over the forecasting years. However, stringent government regulations for the product approval are a restricting the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Inhaled and Intranasal Products Contract Service Providers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the increasing incidences of respiratory disorder, along with the rising government initiatives and implementation of several policies. Whereas, North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as the favorable reimbursement scenario, as well as presence of a large number of contract manufacturers in the market space.
Major market players included in this report are:
Lonza
Catalent Inc.
Kindeva Drug Delivery
Recipharm
Quotient Services
Hovione
Colep
Beximo Pharmaceuticals
DPT Laboratories
Orion
Recent Developments in the Market:
Global Inhaled and Intranasal Products Contract Service Providers Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Services, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Metered - dose Inhalers
Dry Powder Inhalers
Nebulizers
Others
By Services:
Quality Assurance
Regulatory Affair Services
Product Design & Development
Product Maintenance
Contract Manufacturing
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World